People: Myriad Genetics Inc (MYGN.O)
MYGN.O on Nasdaq
31.43USD
24 May 2013
31.43USD
24 May 2013
Price Change (% chg)
$-0.76 (-2.36%)
$-0.76 (-2.36%)
Prev Close
$32.19
$32.19
Open
$32.02
$32.02
Day's High
$32.02
$32.02
Day's Low
$31.02
$31.02
Volume
1,104,565
1,104,565
Avg. Vol
1,178,079
1,178,079
52-wk High
$34.70
$34.70
52-wk Low
$22.02
$22.02
Lanchbury, Jerry
Brief Biography
Dr. Jerry S. Lanchbury, Ph.D., is Chief Scientific Officer of Myriad Genetics, Inc., since February 02, 2010. He joined the Company in September 2002 as Senior Vice President of Research. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named Chief Scientific Officer in February 2010. Dr. Lanchbury came to the Company from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.
Basic Compensation
| Total Annual Compensation, USD | Long-Term Incentive Plans, USD | All Other, USD | Fiscal Year Total, USD |
|---|---|---|---|
| 665,573 | -- | 1,218,130 | 1,883,710 |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | 51,804 | 815,073.00 |
| Name | Fiscal Year Total |
|---|---|
John Henderson |
-- |
Peter Meldrum |
5,951,710 |
Walter Gilbert |
-- |
James Evans |
2,175,360 |
T. Craig Benson |
-- |
Mark Capone |
2,894,360 |
As Of 29 Jun 2012

